Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy Resistant Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01505010
What this trial is testing

Renal Denervation for Management of Drug-Resistant Hypertension

Who this might be right for
Hypertension
KU Leuven 17
Large-scale testing (Phase 3)Study completedNCT00558428
What this trial is testing

Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 1,098
Not applicableStudy completedNCT07183137
What this trial is testing

Metabolic Surgery for Metabolic Syndrome

Who this might be right for
Metabolic Syndrome (MetS)Hypertension (HTN)Obesity+4 more
The Third Xiangya Hospital of Central South University 1,581
Not applicableStudy completedNCT03078244
What this trial is testing

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension

Who this might be right for
Treatment Resistant Hypertension
Emerald Clinical Inc. 1,500
Not applicableStudy completedNCT02513524
What this trial is testing

Prevalence of Resistant Hypertension With DOT

Who this might be right for
Hypertension
Ottawa Hospital Research Institute 60
Post-approval studies (Phase 4)UnknownNCT00637065
What this trial is testing

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more
Royal Brompton & Harefield NHS Foundation Trust 48
Not applicableUnknownNCT05426707
What this trial is testing

Remote Ischemic Conditioning for the Treatment of Resistant Hypertension

Who this might be right for
Resistant Hypertension
Ji Xunming,MD,PhD 40
Post-approval studies (Phase 4)UnknownNCT01643434
What this trial is testing

Resistant Hypertension Optimal Treatment

Who this might be right for
Hypertension
Instituto do Coracao 2,000
Not applicableStudy completedNCT00710190
What this trial is testing

Device Based Therapy in Hypertension Trial

Who this might be right for
Hypertension
CVRx, Inc. 46
Not applicableStudy completedNCT00881985
What this trial is testing

Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant Hypertension

Who this might be right for
Resistant HypertensionObstructive Sleep Apnea
The University of Hong Kong 92
Testing effectiveness (Phase 2)Study completedNCT02133872
What this trial is testing

Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

Who this might be right for
Hypertension
University of Florida 34
Not applicableWithdrawnNCT02077530
What this trial is testing

Metabolic Syndrome Cohort in Korea

Who this might be right for
Metabolic Syndrome
Korea University Anam Hospital
Not applicableStudy completedNCT00370214
What this trial is testing

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Who this might be right for
Pulmonary Hypertension
Actelion 3,515
Testing effectiveness (Phase 2)Study completedNCT04519658
What this trial is testing

CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Who this might be right for
Resistant Hypertension
CinCor Pharma, Inc. 275
Large-scale testing (Phase 3)Ended earlyNCT01762488
What this trial is testing

Renal Denervation in Treatment Resistant Hypertension

Who this might be right for
Hypertension
Henrik Vase 8
Post-approval studies (Phase 4)UnknownNCT00994617
What this trial is testing

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

Who this might be right for
Hypertension, Resistant to Conventional TherapyEssential Hypertension
University of Cambridge 600
Not applicableActive Not RecruitingNCT05017935
What this trial is testing

RADIANCE Continued Access Protocol

Who this might be right for
HypertensionHypertension, Resistant to Conventional TherapyVascular Diseases+1 more
ReCor Medical, Inc. 300
Large-scale testing (Phase 3)Ended earlyNCT00389675
What this trial is testing

DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension

Who this might be right for
Hypertension
Gilead Sciences 661
Testing effectiveness (Phase 2)Ended earlyNCT03273257
What this trial is testing

Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionCTEPH
International CTEPH Association 14
Post-approval studies (Phase 4)Study completedNCT00224549
What this trial is testing

PHARES Study: Management of Resistant Hypertension

Who this might be right for
Hypertension
Assistance Publique - Hôpitaux de Paris 180
Next Page